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BSTRACT
Background:
 
Signal transducers and activators of
transcription 6 (Stat6) is involved in the interleukin
(IL)-4 and IL-13 signaling pathway. The aim of the
present study was to evaluate whether polymorphisms
in the 5
 
′
 
-flanking region of the 
 
Stat6
 
 gene are associ-
ated with allergic diseases in Japanese children.
 
Methods:
 
The 
 
Stat6
 
 gene polymorphisms were geno-
typed by polymerase chain reaction (PCR) fragment
length polymorphism analysis and the IL-4 receptor
Ile50Val polymorphism was examined using PCR
methods.
 
Results:
 
Novel dinucleotide repeat polymorphisms
were found in the 5
 
′
 
-flanking sequences, positioning
at –865 (Pro A) and –690 (Pro B) of the 
 
Stat6
 
 gene
starting codon. The GT repeats in the 5
 
′
 
-flanking
sequences were highly polymorphic (Pro A: 14–29
repeats; ProB: 14–20 repeats) with no significant
differences in the frequency of allelic and genotypic
distributions observed between allergic subjects and
controls. In the GT repeat polymorphism of 
 
Stat6
 
exon 1, there was a significant difference in the
frequency of genotypic distribution between the two
groups (
 
P
 
 = 0.003). The 
 
Stat6
 
 exon 1 variant had
significant linkage disequilibrium with Pro B variants,
but not with Pro A. The GT repeat polymorphism
was  not associated with the IL-4 receptor Ile50Val
polymorphism.
 
Conclusions:
 
Variants of the 
 
Stat6
 
 gene may be
useful markers for predicting allergic diseases in
Japanese children.
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I
 
NTRODUCTION
 
Activation of Signal transducers and activators of tran-
scription 6 (Stat6) correlates with functional responses
induced by interleukin (IL)-4 and IL-13. Binding of these
cytokines to their receptors at the cell surface induces
receptor dimerization and activation of Janus tyrosine
kinases (JAK) 3 and Stat6. Tyrosine phosphorylation of
Stat6 mediates homodimerization, triggering movement
to the nucleus and leading to Stat6 DNA-binding sites in
the promoter sequences in DNA.
 
1–3
 
Phenotypic analysis of Stat6
 
–/–
 
 mice have elegantly
demonstrated a role for Stat6 in IL-4- and IL-13-induced
lymphocyte proliferation, Th2 cell differentiation, immuno-
globulin class switching and major histocompatibility
complex (MHC) class II and CD23 cell surface antigen
expression.
 
2
 
 Furthermore, Stat6
 
–/–
 
 mice were protected
from bronchial eosinophilia and failed to develop airway
hyperresponsiveness after allergen provocation; thus,
Stat6 activation may be closely related to allergic asthma
and other inflammatory and allergic diseases.
 
4,5
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The Th2 cytokines have been suggested as a candi-
date gene for atopy. Several groups have studied the
association of these genetic variants and atopy/allergic
diseases in Western or Japanese populations.
 
6,7
 
 
 
Stat6
 
,
which maps to chromosome 12q13.3-q14.1, represents
one of the most promising candidate genes because
the chromosomal region 12q13-q24 has been shown to
be linked with asthma and related phenotypes.
 
8
 
 Recently,
we reported the association between the dinucleotide
repeat polymorphism of the 
 
Stat6
 
 exon 1 and allergic
subjects in a Japanese population
 
9,10
 
 and another group
has shown that the G2964A variant of the 
 
Stat6
 
 exon 23
gene was associated with mild atopic asthma.
 
11
 
 More
recently, Duetsch 
 
et al
 
. screened all 23 exons of the 
 
Stat6
 
gene and were able to identify 13 single nucleotide poly-
morphisms (SNP), all of which are non-coding; however,
these authors did not find any linkage/association with
asthma for those SNP in their Caucasian sib-pair study.
 
12
 
In the present study, we used the same sample as in
our earlier study
 
10
 
 and undertook a further association
study among the dinucleotide repeat polymorphisms
in the 5
 
′
 
-flanking region and exon 1 of 
 
Stat6
 
 and allergic
subjects, including those with atopic dermatitis (AD),
bronchial asthma (BA) and food-related anaphylaxis
(FA). Furthermore, we examined the relationship between
the GT repeat polymorphism of 
 
Stat6
 
 and the IL-4
receptor 
 
α
 
 chain gene variant (Ile50Val), which has been
reported to be strongly associated with allergic asthma
 
13
 
in a Japanese population.
 
M
 
ETHODS
 
Allergic and control subjects
 
The characteristics of the allergic and control subjects
have been described previously.
 
10
 
 Briefly, 102 children
(average age 11 years; 61 boys and 41 girls) with major
allergic diseases including BA (
 
n
 
 = 71), AD (
 
n
 
 = 47)
and/or FA (
 
n
 
 = 14) were studied. A pediatrician per-
formed a physical examination of each subject. Serum
IgE levels were measured by enzyme-linked immuno-
sorbent assays in 100 patients; the mean IgE level was
2257 IU/L.
Bronchial asthma was diagnosed according to the
criteria of the National Institutes of Health of the US with
minor modification.
 
14
 
 Briefly, the diagnosis of BA was
made based on the appearance of both of the following
characteristics: two or more episodes of wheezing and
shortness of breath during the past year and reversibility
of the wheezing and dyspnea, either spontaneously or
after treatment with a bronchodilator. Because wheezing
is often associated with viral respiratory infection in young
children, subjects more than 3 years of age were evalu-
ated for the asthma phenotype.
The diagnosis of AD was made based on the appear-
ance of active skin disease, the distribution of skin lesions
and the clinical course of the disease according to the
diagnostic criteria of Hanifin and Rajka.
 
15
 
The diagnosis of FA was made based on recognition
of typical manifestations and patient history, with regard
to the reproducibility of the reaction, the timing of the
reaction and the response to the elimination of the food
from the diet. All FA patients had a positive RAST
response to food to which they were susceptible.
Control subjects were 66 individuals (average age
28 years; sex ratio (M : F) 0.56 : 0.44) with no history of
major atopic disease. Informed consent was obtained
from all subjects or their parents. The Committee of
Ethics at the Department of Pediatrics, The University
of Gunma, approved this study.
 
Molecular methods
 
DNA was extracted from peripheral blood leukocytes.
We screened the 5
 
′
 
-flanking sequence of the 
 
Stat6
 
 gene
from 10 subjects for mutations by direct polymerase
chain reaction (PCR) sequencing. We identified an
identical alteration in the 5
 
′
 
-flanking sequence, position-
ing at –865 (Pro A) and –690 (ProB) from the start
codon, of the 
 
Stat6
 
 gene. To genotype the dinucleotide
repeat polymorphism of the first exon and the 5
 
′
 
-flanking
sequence of the 
 
Stat6
 
 gene, as well as the IL-4 receptor
Ile50Val polymorphism, PCR fragment length poly-
morphism analysis was performed according to methods
described previously.
 
9,13
 
Primer sequences
 
The primers for 
 
Stat6
 
 exon 1 were: forward 5
 
′
 
-
GAGGGACCTGGGTAGAAGGA-3
 
′
 
; reverse 5
 
′
 
-CAC
CCCCATGCACTCATAG-3
 
′
 
.
The primers for 
 
Stat6
 
 pro A were: forward 5
 
′
 
-
GGGCTCTGTTTGTGAGCCTG-3
 
′
 
; reverse 5
 
′
 
-TTCCG
GCTTCTCCTTCTACC-3
 
′
 
.
The primers for 
 
Stat6
 
 pro B were: forward 5
 
′
 
-
GGGAGTAAAGGCCTCTCTGG-3
 
′
 
; reverse 5
 
′
 
-ACGT
GCAGGCAGGCTCACAA-3
 
′
 
.
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Polymerase chain reaction conditions
 
The PCR reactions were performed in a volume of 25 
 
µ
 
L
containing 50 ng genomic DNA, each dNTP at
125 
 
µ
 
mol/L, 2 U 
 
Taq
 
 polymerase, 
 
Taq
 
 buffer and
10 pmol forward and reverse primers. For 
 
Stat6
 
 exon 1,
the 6-carboxy fluorescein (6-FAM)-labeled forward primer
was used. Cycle conditions were 95
 
°
 
C for 5 min and then
40 cycles of 95
 
°
 
C for 30 s, 66
 
°
 
C (
 
Stat6
 
 exon 1) or 60
 
°
 
C
(Pro A, Pro B and IL-4 receptor 
 
α
 
 chain (IL-4R
 
α
 
)) for 30 s
and 72
 
°
 
C for 30 s, with a final extension step of 7 min at
72
 
°
 
C in a GeneAmp 2400 thermocycler (Perkin Elmer,
Norwalk, CA, USA). After PCR, a 1 
 
µ
 
L aliquot of the
products plus 0.5 
 
µL Genescan 400HD molecular weight
standard (Applied Biosystems, Foster City, CA, USA) was
denatured in 12 µL formamide, separated in an Applied
Biosystems Prism Genetic Analyzer (ABI PRISMTM310) with
performance optimized polymer 6 (POP6) polymer and
fragment lengths determined.
Polymerase chain reaction–restriction 
fragment length polymorphism analysis
The Ile50Val polymorphism was genotyped by PCR–
restriction fragment length polymorphism (RFLP) analysis
using the primer pair 5′-GGCAGGTGTGAGGAG
CATCC, 252–233 bp upstream of the Ile50Val poly-
morphic site, and 5′-GCCTCCGTTGTTCTCAGGTA.
The original sequence of positions 399–418 in the IL-4
receptor gene sequence for the downstream primer is
TCCCTGAGAACAACGGAGGC (GCCTCCGTTGTTCT
CAGGGA for the reverse sequence). A mismatch was
introduced in the downstream primer to obtain the RsaI
restriction site.
Statistical analysis
Data were analyzed by Chi-squared test. P < 0.05 was
considered significant.
RESULTS
Subjects with allergic diseases and controls were geno-
typed in terms of the GT repeat polymorphism in exon 1,
Pro A and Pro B of the Stat6 gene. The polymorphic PCR
products were classified into four alleles (13–16 GT
repeats) in the first exon,9 15 alleles (14–29) in Pro A
and seven alleles (14–20) in Pro B of Stat6 (Table 1).
Table 1 Allelic distributions of Pro A and Pro B in the Stat6 gene polymorphism in Japanese patients with allergic diseases
and controls
No. GT repeats Allergy Control P
Subjects (n) Frequency Subjects (n) Frequency
Pro A 14 1 0.005 0 0.000 0.826
16 1 0.005 0 0.000 0.826
17 13 0.064 7 0.053 0.866
18 5 0.025 1 0.008 0.47
19 0 0.000 1 0.008 0.826
20 3 0.015 8 0.061 0.046
21 11 0.054 4 0.030 0.451
22 18 0.088 15 0.114 0.564
23 58 0.284 38 0.288 0.958
24 41 0.201 18 0.136 0.17
25 10 0.049 12 0.091 0.197
26 13 0.064 6 0.045 0.641
27 17 0.083 10 0.076 0.965
28 9 0.044 5 0.038 1
29 4 0.020 7 0.053 0.171
Total 204 1 132 1
Pro B 14 27 0.132 15 0.114 0.884
15 2 0.010 2 0.015 0.941
16 114 0.559 84 0.636 0.194
17 14 0.069 4 0.030 0.202
18 43 0.211 16 0.121 0.05
19 2 0.010 9 0.068 0.009
20 2 0.010 2 0.015 0.941
Total 204 1 132 1
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We designated an individual homozygous for the
most commonly occurring allele (exon 1: (GT)15, Pro A:
(GT)23 and Pro B: (GT)16) as the wild type, an individual
without a shorter repeat allele (exon 1: (GT)13 and
(GT)14, Pro A: less than (GT)23 and Pro B: (GT)14
and (GT)15) as mutant 1 type and an individual having
one or two shorter repeat alleles as mutant 2 type
(Table 2). In the first exon of the GT repeat polymor-
phism, the frequency of individuals with mutant 2 but not
mutant 1 type was significantly higher in allergic subjects
than in controls, compared with that of the wild type
(P = 0.003; odds ratio (OR) 2.89, 95% confidence inter-
val (CI) 1.42–5.88). However, no significant differences
in the frequency of genotypic distribution in Stat6 Pro A
and Pro B were observed between the two groups.
When we examined the association with the GT repeat
polymorphism in exon 1 and Pro B of Stat6, there was a
significant linkage disequilibrium between the (GT)15
in exon 1 and the (GT)16 allele in Pro B of Stat6
(P = 3.49 × 10–12; OR 11.8, 95%CI 5.59–24.95;
Table 3). However, there was no significant linkage dis-
equilibrium between Pro A and exon 1. The frequencies
of the Ile50Val polymorphism of the IL-4R gene were
similar in allergic subjects and control groups (Table 4).
Furthermore, the GT repeat polymorphism in Stat6
exon 1 was not associated with the IL-4 receptor Ile50Val
polymorphism.
DISCUSSION
In the present study, no significant association was found
between the 5′-flanking region variants of the Stat6 gene
and any allergic subjects in our Japanese population,
whereas the frequency of a shorter repeat allele (13 and
14GT repeats) of Stat6 exon 1 was significantly related
to allergic diseases. Strong linkage disequilibrium was
observed between the 5′-flanking region (Pro B) and
exon 1 of the Stat6 gene. Our data suggest that the GT
repeat polymorphism in the Stat6 gene may play an
important role in the development of allergic disease in
Japanese children.
Patel et al.16 found that the KpnI-NheI fragment
(approximately –5500 to +134 bp from the start codon)
isolated as the 5′-flanking region of human Stat6
contained a functional promoter. Furthermore, maximal
constitutive transcriptional activity was observed with the
Table 2 Genotypic distribution of the Stat6 polymorphism in controls and allergic subjects in a Japanese population
Allergic 
(n = 102)
Control 
(n = 66)
P† Odds ratio (95%CI)
Exon 1 Wild type 29 32
Mutant 1 18 13 0.340
Mutant 2 55 21 0.003 2.89 (1.42–5.88)
ProA Wild type 11 6
Mutant 1 45 27 0.866
Mutant 2 46 33 0.622
ProB Wild type 33 28
Mutant 1 42 21 0.152
Mutant 2 27 17 0.458
†Wild type versus mutant 1 or mutant 2.
Refer to the text for details of the definitions of wild type, mutant 1 and mutant 2.
Table 3 Linkage disequilibrium between Stat6 exon 1 (GT)n and Stat6 5′-flanking region Pro A or Pro B(GT)n polymorphisms
Exon 1 P
Wild type  Others
ProA Wild type 9 8 0.132
Others 52 99
ProB Wild type 43 18 3.492 × 10–12
Others 18 89 OR (95%CI): 11.8 (5.59–24.95)
Others = mutant 1 + mutant 2; OR, odds ratio; CI, confidence interval.
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5′-deletion constructs (–947 to +134 bp). Subsequent
deletion constructs (–543 to +134 bp) resulted in reduced
transcriptional activity, suggesting that the regions (–947
to –543) in the Stat6 gene may play an important role for
transcriptional activity. Therefore, variants of these regions
may induce changes in transcription activities. In the
present study, we found highly polymorphic GT repeats in
the 5′-flanking sequence, positioning at –865 bp (Pro A)
and –690 bp (Pro B) from the start codon of the Stat6
gene. However, contrary to our expectations, there were
no significant differences in the frequencies of genotypic
distributions of Stat6 Pro A and Pro B between allergic
and control subjects.
In a recent study,9,10 we found a significant association
between the 13/15GT repeat allele heterozygosity of the
stat6 gene and allergic subjects in a Japanese popula-
tion. In the present study, using the same subject source
as previously, we analyzed individuals for the type most
commonly occurring or not in terms of wild or mutant
types, which consist of an allele. As a result, a significant
difference in the frequency of genotypic distribution was
observed between the two groups in the GT repeat poly-
morphism, especially shorter repeats (13 and 14 GT
repeat), in the first exon of the Stat6 gene. This exon is a
non-coding region but, directly or indirectly, it may influ-
ence a regulatory element and would be an abnormal
translation of the Stat6 mRNA. Perhaps the repeat
number may be an important factor for the modulation of
gene expression. Indeed, recent studies have shown that
dinucleotide repeats can influence the transcription or
translation of genes. Gabellini demonstrated that a GT
repeat in intron 2 of the human cardiac Na+Ca2+
exchanger gene (NCX1) functions as a strong intronic
splicing enhancer that could be involved in the regulation
of NCX1 expression.17 Buerger et al. also found that the
number of CA repeats in intron 1 of the epithelial growth
factor receptor (EGFR) gene correlated with the expres-
sion of EGFR in vitro and in vivo.18 These results suggest
that the function of microsatellites may be correlated with
individual differences in gene expression.
In the association study with the GT repeat polymor-
phism of the Stat6 exon 1, we showed significant linkage
disequilibrium between the 16 GT repeat homozygosity
of the 5′-flanking region (Pro B) and the 15 GT repeat
homozygosity of Stat6 exon 1.
In contrast with the data of Mitsuyasu et al.,13 we could
not confirm a significant association between the IL-4R
Ile50Val variant and any other allergic subjects in our
Japanese population. Another group was also unable to
replicate this association,19 perhaps suggesting that there
are marked differences not only between different ethnic
groups, but also within a single ethnic group, which
underlines the genetic heterogeneity of complex diseases
such as allergic diseases. Furthermore, this polymorphism
was not linked with the GT repeat polymorphisms in the
first exon of Stat6.
We have demonstrated previously that the levels of IgE
are not related to the GT repeat polymorphism in stat6
exon 1 in allergic subjects.9 In addition, 5′-flanking
region variants were not correlated with the level of IgE
(data not shown), suggesting that regulation of IgE pro-
duction by these polymorphisms is unlikely to predispose
individuals to allergic diseases. However, although the
GT repeat polymorphisms may promote allergic disease
by the development of bronchial hyperresponsiveness or
by some other mechanism, the true mechanism predis-
posing individuals to allergic diseases remains unknown.
Further analysis of different clinical expressions is needed
and should assist in elucidating the role of the GT repeat
polymorphisms.
The small sample size was a limiting factor in the
present study and further association studies will be
needed to elucidate the role of stat6 gene polymorphisms
in the development of each allergic phenotype, including
BA, AD, allergic rhinitis and food allergy. In addition,
functional analyses of Stat6 will be needed to elucidate
the role of the Stat6 gene in the development of allergic
disease.
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